{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:31:17Z","timestamp":1789965077186,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10620-017-4564-4","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T02:28:15Z","timestamp":1491618495000},"page":"1580-1589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection"],"prefix":"10.1007","volume":"62","author":[{"given":"Wei","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"key":"4564_CR1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/hel.12046","volume":"18","author":"P Su","year":"2013","unstructured":"Su P, Li Y, Li H, et al. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter. 2013;18:274\u2013279.","journal-title":"Helicobacter"},{"key":"4564_CR2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.dld.2014.08.038","volume":"46","author":"Z Song","year":"2014","unstructured":"Song Z, Zhang J, He L, et al. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Dig Liver Dis. 2014;46:1077\u20131081.","journal-title":"Dig Liver Dis"},{"key":"4564_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34\u201342.","journal-title":"Gut"},{"key":"4564_CR4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, et al. Management of Helicobacter pylori infection\u2013the Maastricht IV\/Florence Consensus Report. Gut. 2012;61:646\u2013664.","journal-title":"Gut"},{"key":"4564_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"PMF Malfertheiner","year":"2017","unstructured":"Malfertheiner PMF, O\u2019Morain CAGJP, Kuipers EJ. Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report. Gut. 2017;66:6\u201330.","journal-title":"Gut"},{"key":"4564_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/1751-2980.12034","volume":"14","author":"WZ Liu","year":"2013","unstructured":"Liu WZ, Xie Y, Cheng H, et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis. 2013;14:211\u2013221.","journal-title":"J Dig Dis"},{"key":"4564_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59:1143\u20131153.","journal-title":"Gut"},{"key":"4564_CR8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.anai.2014.02.005","volume":"112","author":"ME Pichichero","year":"2014","unstructured":"Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. Ann Allergy Asthma Immunol. 2014;112:404\u2013412.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"4564_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","volume":"45","author":"R Mirakian","year":"2015","unstructured":"Mirakian R, Leech SC, Krishna MT, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015;45:300\u2013327.","journal-title":"Clin Exp Allergy"},{"key":"4564_CR10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.otohns.2006.10.007","volume":"136","author":"ME Pichichero","year":"2007","unstructured":"Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis. Otolaryngol Head Neck Surg. 2007;136:340\u2013347.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4564_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.31.9.973","volume":"31","author":"M Tatsuta","year":"1990","unstructured":"Tatsuta M, Ishikawa H, Iishi H, Okuda S, Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut. 1990;31:973\u2013976.","journal-title":"Gut"},{"key":"4564_CR12","first-page":"309","volume":"55","author":"S Fagoonee","year":"2013","unstructured":"Fagoonee S, Astegiano M, Smedile A, Pellicano R. Efficacy of cefixime-based triple therapy for Helicobacter pylori eradication: A retrospective study. Panminerva Med. 2013;55:309\u2013310.","journal-title":"Panminerva Med"},{"key":"4564_CR13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/1751-2980.12271","volume":"16","author":"P Bai","year":"2015","unstructured":"Bai P, Zhou LY, Xiao XM, Luo Y, Ding Y. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients. J Dig Dis. 2015;16:464\u2013470.","journal-title":"J Dig Dis"},{"key":"4564_CR14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","volume":"42","author":"JD Campagna","year":"2012","unstructured":"Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: A literature review. J Emerg Med. 2012;42:612\u2013620.","journal-title":"J Emerg Med"},{"key":"4564_CR15","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.diagmicrobio.2006.12.004","volume":"57","author":"ME Pichichero","year":"2007","unstructured":"Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: A paradigm shift. Diagn Microbiol Infect Dis. 2007;57:13S\u201318S.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4564_CR16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0091-6749(96)70101-X","volume":"98","author":"A Miranda","year":"1996","unstructured":"Miranda A, Blanca M, Vega JM, et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol. 1996;98:671\u2013677.","journal-title":"J Allergy Clin Immunol"},{"key":"4564_CR17","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161\u20131181.","journal-title":"Am J Surg Pathol"},{"key":"4564_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/hel.12242","volume":"21","author":"L Zhou","year":"2016","unstructured":"Zhou L, Zhang J, Song Z, et al. Tailored versus triple plus bismuth or concomitant therapy as initial Helicobacter pylori treatment: A randomized trial. Helicobacter. 2016;21:91\u201399.","journal-title":"Helicobacter"},{"key":"4564_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ajg.2014.26","volume":"109","author":"L Zhou","year":"2014","unstructured":"Zhou L, Zhang J, Chen M, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: A randomized multicenter trial. Am J Gastroenterol. 2014;109:535\u2013541.","journal-title":"Am J Gastroenterol"},{"key":"4564_CR20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","volume":"64","author":"W Zhang","year":"2015","unstructured":"Zhang W, Chen Q, Liang X, et al. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015;64:1715\u20131720.","journal-title":"Gut"},{"key":"4564_CR21","first-page":"121.e1","volume":"145","author":"J Molina-Infante","year":"2013","unstructured":"Molina-Infante J, Romano M, Fernandez-Bermejo M, et al. Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. Gastroenterology. 2013;145:121.e1\u2013128.e1.","journal-title":"Gastroenterology"},{"key":"4564_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","volume":"381","author":"JM Liou","year":"2013","unstructured":"Liou JM, Chen CC, Chen MJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial. Lancet. 2013;381:205\u2013213.","journal-title":"Lancet"},{"key":"4564_CR23","first-page":"1134","volume":"25","author":"H Lu","year":"2013","unstructured":"Lu H, Zhang W, Graham DY. Bismuth-containing quadruple therapy for Helicobacter pylori: Lessons from China. Eur J Gastroenterol Hepatol. 2013;25:1134\u20131140.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4564_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/hel.12052","volume":"18","author":"J Liao","year":"2013","unstructured":"Liao J, Zheng Q, Liang X, et al. Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013;18:373\u2013377.","journal-title":"Helicobacter"},{"key":"4564_CR25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gtc.2015.05.002","volume":"44","author":"F M\u00e9graud","year":"2015","unstructured":"M\u00e9graud F, B\u00e9n\u00e9jat L, Ontsira NEN, Lehours P. Molecular approaches to identify Helicobacter pylori antimicrobial resistance. Gastroenterol Clin N Am. 2015;44:577\u2013596.","journal-title":"Gastroenterol Clin N Am"},{"key":"4564_CR26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/jac\/dkf041","volume":"49","author":"Z Samra","year":"2002","unstructured":"Samra Z, Shmuely H, Niv Y, et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother. 2002;49:1023\u20131026.","journal-title":"J Antimicrob Chemother"},{"key":"4564_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/hel.12287","volume":"21","author":"DY Graham","year":"2016","unstructured":"Graham DY. Hp-normogram (normo-graham) for assessing the outcome of H. pylori therapy: Effect of resistance, duration, and CYP2C19 genotype. Helicobacter. 2016;21:85\u201390.","journal-title":"Helicobacter"},{"key":"4564_CR28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.13346","volume":"42","author":"EA Marcus","year":"2015","unstructured":"Marcus EA, Sachs G, Scott DR. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics. Aliment Pharmacol Ther. 2015;42:922\u2013933.","journal-title":"Aliment Pharmacol Ther"},{"key":"4564_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MCG.0b013e318254ebdd","volume":"47","author":"JP Gisbert","year":"2013","unstructured":"Gisbert JP, Perez-Aisa A, Bermejo F, et al. Second-line therapy with levofloxacin after failure of treatment to eradicate Helicobacter pylori infection: Time trends in a Spanish Multicenter Study of 1000 patients. J Clin Gastroenterol. 2013;47:130\u2013135.","journal-title":"J Clin Gastroenterol"},{"key":"4564_CR30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","volume":"65","author":"MP Dore","year":"2016","unstructured":"Dore MP, Lu H, Graham DY. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016;65:870\u2013878.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:38:20Z","timestamp":1495525100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4564"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4564-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}